NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 350 filers reported holding NATERA INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $29,261,000 | -33.3% | 313,320 | -20.4% | 3.78% | -26.3% |
| Q3 2021 | $43,865,000 | -1.8% | 393,620 | 0.0% | 5.13% | +23.0% |
| Q2 2021 | $44,688,000 | +13.2% | 393,620 | +1.3% | 4.17% | +13.2% |
| Q1 2021 | $39,460,000 | -43.7% | 388,620 | -44.8% | 3.68% | -31.0% |
| Q4 2020 | $70,067,000 | -26.3% | 704,050 | -46.5% | 5.34% | -29.7% |
| Q3 2020 | $95,072,000 | +31.2% | 1,316,052 | -9.5% | 7.60% | +13.3% |
| Q2 2020 | $72,482,000 | +56.1% | 1,453,707 | -6.5% | 6.71% | +24.9% |
| Q1 2020 | $46,427,000 | +10.0% | 1,554,808 | +24.1% | 5.37% | +76.5% |
| Q4 2019 | $42,205,000 | – | 1,252,746 | – | 3.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |